Entity Details
| Primary name |
PDCD1_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q15116 |
| EntryName | PDCD1_HUMAN |
| FullName | Programmed cell death protein 1 |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 288 |
| SequenceStatus | complete |
| DateCreated | 1997-11-01 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Cell membrane |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR003599 | Immunoglobulin subtype | Domain | Domain |
| IPR007110 | Immunoglobulin-like domain | Domain | Domain |
| IPR013106 | Immunoglobulin V-set domain | Domain | Domain |
| IPR013783 | Immunoglobulin-like fold | Family | Homologous superfamily |
| IPR036179 | Immunoglobulin-like domain superfamily | Family | Homologous superfamily |
| IPR042379 | Programmed cell death protein 1 | Family | Family |
Drugs
Show/Hide Table
| Drug | Name | Source | Type |
| DB05916 | CT-011 | Drugbank | biotech |
| DB09035 | Nivolumab | Drugbank | biotech |
| DB09037 | Pembrolizumab | Drugbank | biotech |
| DB14707 | Cemiplimab | Drugbank | biotech |
| DB14776 | Camrelizumab | Drugbank | biotech |
| DB14892 | Spartalizumab | Drugbank | biotech |
| DB14922 | Tislelizumab | Drugbank | biotech |
| DB15043 | Toripalimab | Drugbank | biotech |
| DB15627 | Dostarlimab | Drugbank | biotech |
| DB15765 | Sintilimab | Drugbank | biotech |
| DB15766 | Retifanlimab | Drugbank | biotech |
| DB15767 | AMP-224 | Drugbank | biotech |
| DB15768 | MEDI0680 | Drugbank | biotech |
Interactions
5 interactions